FDA 510(k) Clearance of the Levo Gen2 Tinnitus Therapy System (K260413)

The FDA determined substantial equivalence for the Levo Gen2 Tinnitus Therapy System (K260413) as a
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 Next

FDA 510(k) Clearance of the Levo Gen2 Tinnitus Therapy System (K260413)

The FDA determined substantial equivalence for the Levo Gen2 Tinnitus Therapy System (K260413) as a
Prev 1 2 3 4 Next
Prev 1 2 3 4 5 6 7 Next

New therapy helps reduce tinnitus symptoms

The treatment reproduces the sound of the patient’s tinnitus in a personalized way, helping the brai
Prev 1 2 Next
All
Press
Research
Certifications
Videos

FDA 510(k) Clearance of the Levo Gen2 Tinnitus Therapy System (K260413)

The FDA determined substantial equivalence for the Levo Gen2 Tinnitus Therapy System (K260413) as a

Medical technology for tinnitus treatment reaches international media

An international media outlet presents how the therapeutic system works, along with testimonials fro

New therapy helps reduce tinnitus symptoms

The treatment reproduces the sound of the patient’s tinnitus in a personalized way, helping the brai

U.S. hospital applies personalized sound therapy for tinnitus treatment

A television report from a U.S. medical center shows how specialists measure each patient’s tinnitus

The Levo System Wins Top Honors at the 2017 Medical Design Excellence Awards

PORTLAND, Ore., Otoharmonics today announced that the Levo System has been awarded the top prize in

Patients reduce tinnitus following neurological treatment during sleep

This report presents a neuroplasticity-based therapy that reproduces the patient’s internal sound in

New therapy helps reduce tinnitus symptoms

The treatment reproduces the sound of the patient’s tinnitus in a personalized way, helping the brai

The Levo System Wins Top Honors at the 2017 Medical Design Excellence Awards

PORTLAND, Ore., Otoharmonics today announced that the Levo System has been awarded the top prize in

FDA 510(k) Clearance of the Levo Gen2 Tinnitus Therapy System (K260413)

The FDA determined substantial equivalence for the Levo Gen2 Tinnitus Therapy System (K260413) as a

Medical technology for tinnitus treatment reaches international media

An international media outlet presents how the therapeutic system works, along with testimonials fro

U.S. hospital applies personalized sound therapy for tinnitus treatment

A television report from a U.S. medical center shows how specialists measure each patient’s tinnitus

Patients reduce tinnitus following neurological treatment during sleep

This report presents a neuroplasticity-based therapy that reproduces the patient’s internal sound in

Contact

Briefly tell us about your case, and a member of our clinical team will get back to you to coordinate the first step.

What happens after you submit the form?

  • We review your submission and propose available time slots for your evaluation.

  • If appropriate, we send you an initial questionnaire to better understand your hearing profile.

  • We guide you on the consultation format (in-person or remote) and the next steps.


Subscription confirmed!You are now part of Levomedical updates.